We are live on ! Find out more
TCA

Troluce Capital Advisors Portfolio holdings

AUM $1.63B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+1.06%
1 Year Est. Return
+37.23%
3 Year Est. Return
+85.16%
5 Year Est. Return
10 Year Est. Return
AUM
$1.02B
AUM Growth
+$193M
Cap. Flow
+$210M
Cap. Flow %
20.55%
Top 10 Hldgs %
40.89%
Holding
120
New
39
Increased
12
Reduced
11
Closed
47

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$29.4M
2
COF icon
Capital One
COF
+$26.1M
3
TKO icon
TKO Group
TKO
+$20.2M
4
AER icon
AerCap
AER
+$15.3M
5
ALTM
Arcadium Lithium plc
ALTM
+$11M

Sector Composition

Rank Sector Weight
1 Technology 9.19%
2 Communication Services 7.74%
3 Financials 7.35%
4 Materials 5.37%
5 Healthcare 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AON icon
51
Aon
AON
$81.4B
$5.5M 0.54%
18,734
-14,566
-44% -$4.31M
FLUT icon
52
Flutter Entertainment
FLUT
$18.9B
$5.47M 0.54%
30,000
-26,937
-47% -$5.18M
CYTK icon
53
CALL
Cytokinetics
CYTK
$10.8B
$5.42M 0.53%
100,000
-75,000
-43% -$4.53M
TMUS icon
54
PUT
T-Mobile US
TMUS
$196B
$5.29M 0.52%
+30,000
New +$5.03M
ALIT icon
55
Alight
ALIT
$523M
$4.98M 0.49%
+33,750
New +$5.62M
ALNY icon
56
PUT
Alnylam Pharmaceuticals
ALNY
$38.5B
$4.86M 0.48%
20,000
LSXMK
57
CALL
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$4.43M 0.43%
200,000
LLYVA icon
58
Liberty Live Group Series A
LLYVA
$9.15B
$4.03M 0.4%
+107,495
New +$4.02M
JNPR
59
CALL
DELISTED
Juniper Networks
JNPR
$3.65M 0.36%
100,000
-200,000
-67% -$7.1M
ALTM
60
CALL
DELISTED
Arcadium Lithium plc
ALTM
$3.36M 0.33%
1,000,000
CPRI icon
61
CALL
Capri Holdings
CPRI
$1.88B
$3.31M 0.32%
100,000
-100,000
-50% -$3.62M
SRCL
62
DELISTED
Stericycle Inc
SRCL
$2.91M 0.28%
+50,000
New +$2.57M
HTZWW
63
Hertz Global Holdings Warrants
HTZWW
$71.1M
0
AVDL
64
DELISTED
Avadel Pharmaceuticals
AVDL
$2.11M 0.21%
+150,000
New +$2.44M
ACI icon
65
Albertsons Companies
ACI
$5.67B
$1.98M 0.19%
+100,000
New +$2.04M
DYN icon
66
CALL
Dyne Therapeutics
DYN
$4.28B
$1.76M 0.17%
+50,000
New +$1.45M
CYTK icon
67
Cytokinetics
CYTK
$10.8B
$1.65M 0.16%
+30,398
New +$1.83M
ACI icon
68
CALL
Albertsons Companies
ACI
$5.67B
$988K 0.1%
50,000
TCRX icon
69
TScan Therapeutics
TCRX
$50.6M
$543K 0.05%
+92,832
New +$731K
CPRI icon
70
Capri Holdings
CPRI
$1.88B
$387K 0.04%
11,690
+1,500
+15% +$54.3K
MAXN
71
PUT
DELISTED
Maxeon Solar Technologies
MAXN
$68.2K 0.01%
800
AER icon
72
AerCap
AER
$24.3B
$41.3K ﹤0.01%
443
-171,857
-100% -$15.3M
AAPL icon
73
Apple
AAPL
$4.99T
-10,400
Closed -$1.78M
ALB icon
74
CALL
Albemarle
ALB
$13.3B
-100,000
Closed -$13.2M
APO icon
75
Apollo Global Management
APO
$71.9B
-67,500
Closed -$7.59M

Similar funds

Troluce Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Troluce Capital Advisors held 120 positions worth $1.02B, up 23% from $827M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Troluce Capital Advisors deployed $210M of net new capital in Q2 2024, opening 39 new positions and adding to 12 existing holdings. Its largest new stake was Roivant Sciences: 2,950,000 shares worth $31.2M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8.3% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was AerCap, an estimated $15.3M trimmed.

  • Troluce Capital Advisors's largest Q2 2024 buy was Roivant Sciences: 2,950,000 shares worth $31.2M.
  • Troluce Capital Advisors added most to Liberty Media Corporation Series C Liberty SiriusXM Common Stock in Q2 2024, an estimated $29.8M increase.
  • Troluce Capital Advisors's biggest Q2 2024 reduction was AerCap, cutting an estimated $15.3M.
  • Troluce Capital Advisors fully exited GE Aerospace in Q2 2024, selling an estimated $29.4M.
  • Troluce Capital Advisors's ten largest holdings make up 41% of its $1.02B portfolio in Q2 2024.
  • Troluce Capital Advisors opened 39 new positions and closed 47 in Q2 2024.
  • Troluce Capital Advisors's portfolio value rose 23% quarter-over-quarter to $1.02B.

Based on Troluce Capital Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.